AG1
PrivateLast Round
VC Round
Jan 25, 2022
Est. Valuation
$1.32B
Company Overview
AG1 operates in Consumer & Commerce and is based in Carson City, Nevada. Its latest recorded funding round was a VC Round in January 2022.
AG1 is a health and wellness company that produces a daily nutritional supplement powder designed to support foundational health, energy, and gut function.
Sector
Consumer & Commerce
Verticals
D2C Brands, Subscription Commerce, Sports & Fitness
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AG1 Comparables
Compare AG1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Danone | 89% | |
| Verve | 85% | |
| Primal Harvest | 81% |
For institutional investors. Book with your work email.
AG1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 25, 2022 | ||||
| VC Round | Jul 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AG1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Not Boring Capital | VC Round |
| Bolt Ventures | VC Round |
| SC.Holdings | VC Round |
| G9 Ventures | VC Round |
| Alpha Wave Global | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Partnered with the Rodale Institute on soil health and nutrition.
- Jan 30, 2026
Partnered with Irish Rugby across all levels of the sport.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 10, 2026
AG1 introduces Creatine Formulated by AG1 as a daily creatine product that supports cellular energy, muscle strength and recovery, and cognitive function on Nov 10th '26.
For institutional investors. Book with your work email.
AG1 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AG1's valuation, stock price, and market status.
Is AG1 a public or private company?
AG1 is a private company.
What is the current stock price of AG1?
AG1 is a private company, so its shares have no public market price. Caplight tracks AG1's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AG1 worth (valuation)?
AG1's valuation is estimated at $1.3B based on funding round data.
Can I buy AG1 stock?
AG1 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AG1's last funding round?
AG1's most recent funding round was VC Round on January 25, 2022.
Who are the main investors in AG1?
Key investors in AG1 include SC.Holdings, Alpha Wave Global.
Will AG1 IPO soon?
No public IPO plans have been announced for AG1.
How can I track AG1 secondary market activity?
Caplight tracks bids, offers, and trades in AG1's shares on secondary markets.